US PROSTATE CANCER FOUNDATION: This year’s annual conference of the American Society of Clinical Oncology was uneventful and thus somewhat disappointing in terms of findings that would suddenly lengthen the survival of men with advanced prostate cancer in 2011. READ MORE>
Archive for the ‘FUTURE PROSPECTS’ Category
US cancer conference offered little that was new to prostate cancver sufferers
Posted in FUTURE PROSPECTS, tagged American Society of Clinical Oncology, cancer research, catheter, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, US Prostate Cancer Foundation on September 1, 2010| Leave a Comment »
Survival rates for cancer patients have doubled in a generation
Posted in FUTURE PROSPECTS, PROSTATE CANCER, PROSTATE RESEARCH, tagged cancer death sentence, cancer research, catheter, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate treatment debate, Survival rates for cancer, UK TELEGRAPH on July 13, 2010| Leave a Comment »
UK TELEGRAPH: Survival rates for cancer patients have doubled in a generation, bringing hope that diagnosis of the disease is not the death sentence once feared. READ MORE>
Better prostate prospects as we get older
Posted in Age factors, FUTURE PROSPECTS, PROSTATE CANCER, PROSTATE RESEARCH, tagged advanced prostate cancer, cancer research, catheter, Erectile function, Incontinence, overall life expectancy, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment debate, quality of life, quality of life for older people, Screening debate, survival, URO TODAY on June 20, 2010| Leave a Comment »
URO TODAY: As overall life expectancy grows, clinicians will be confronted more often with diseases that will not affect survival and possibly even quality of life for older people. Prostate cancer is an example of this. READ MORE>
Focus moves to what medicine can do about advanced prostate cancer
Posted in FUTURE PROSPECTS, New prostate drugs, PROSTATE CANCER, PROSTATE RESEARCH, tagged advanced prostate cancer, cancer research, catheter, future treatment of advanced prostate cancer, medical oncology community, Mike Scott, New Prostate Cancer Info-link, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments on June 12, 2010| Leave a Comment »
NEW PROSTATE CANCER INFOLINK: When it comes to prostate cancer, one of the really key issues taxing the medical oncology community over the past few days has been: “How do we need to start thinking about the future treatment of advanced prostate cancer?” READ MORE>
Mike Scott provides a list of new drugs and treatments that are now approved or in prospect for treating advanced prostate cancer.
PROSTATE SCREENING: Hope for better prostate cancer test
Posted in Diagnosis, FUTURE PROSPECTS, Genetic testing, New tests, PROSTATE CANCER, PROSTATE RESEARCH, Screening debate, tagged American Society of Clinical Oncology, better prostate cancer test, cancer research, NEWSDAY, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate treatment, Screening debate on June 12, 2009| Leave a Comment »
JUNE 12: NEWSDAY: Hope for a better prostate cancer test, potential new uses for a largely discredited lung cancer drug and a warning for breast cancer patients all emerged last week from a meeting of the American Society of Clinical Oncology in Orlando, Florida. READ MORE>
PROSTATE DETECTION: Future tests will embrace range of markers and data
Posted in Biomarkers, Diagnosis, Digital exams, FUTURE PROSPECTS, New tests, PROSTATE CANCER, Prostate prognosis, PROSTATE RESEARCH, PSA tests, Screening debate, tagged Biomarkers, blood tests, cancer research, complex assays systems, digital examination, New Prostate Cancer Info-link, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer detection, prostate cancer risk, prostate-specific antigen, PSA, PSA test, Screening debate, urine tests on May 31, 2009| Leave a Comment »
MAY 31: NEW PROSTATE CANCER INFO-LINK: The future of prostate cancer detection may lie in complex assays systems that can test for several markers at the same time and use the accumulated data to assess prostate cancer risk. READ MORE>